by Mischler MarCom | Dec 3, 2024 | Company News, Equities Market Commentary, Recent Deals
Mischler Financial Group’s Month-End (November) Equities Commentary, with a look to the final weeks of 2024 is available via link below. With the US Elections behind us, a new White House Administration in front of us, and US equities continuing to make new highs...
by Mischler MarCom | Nov 19, 2024 | Company News, Debt Market Commentary, Equities Market Commentary, Recent Deals
This past Friday (November 15), LTG H.R. McMaster, the nation’s 25th National Security Advisor, and now Special Advisor to Mischler Financial Group, sat down with Mischler CEO & Principal Dean Chamberlain for a special “Geostrategic SITREP” that is designed to...
by Mischler MarCom | Aug 29, 2024 | Company News, Equities Market Commentary, Recent Deals
#2 H.R. McMaster: Russia | Ukraine Update: What is the Real Objective? #3 H.R. McMaster : The Middle East Theatre: Strait of Hormuz – Is an Energy Security Crisis in the Cards? #4 H.R. McMaster ; The US & China: Investable Yet?? Is There a Face Saving...
by Mischler MarCom | Aug 13, 2024 | Company News, Recent Deals
On Aug 12 2024, Mischler Financial Group’s Special Advisor, and former National Security Advisor to the President LTG H.R. McMaster (Ret) provided his views via the most recent in a series of Geopolitical/Global Macro “SITREPs” The topics General McMaster touched on...
by Mischler MarCom | Aug 1, 2024 | Company News, Equities Market Commentary, Recent Deals
The Mischler Capital Markets’ June end-of-month equities market commentary pointed to the nearly historic negative correlation between major market stock indices, as mid-cap stocks and utilities caught up to the upward moves in big cap techs. In that spirit,...
by Mischler MarCom | Jun 3, 2024 | Company News, Equities Market Commentary, Recent Deals
April Showers > May Flowers> Then Meh, Then the Month-End Mark-Up….. What Really Happened…Earnings Beats; Margins Better; Utes Make Historic Moves; Outlooks Tempered (Again) Mixed Bags; What Keeps F500 CEOs and CFOs up at night now? Generative AI: Should the FDA...
